Science & ResearchAug 5, 2026
Membranolytic peptide programs immunogenic cell death for cancer therapy.
A rational design for facilitating innovative cell death modes can substantially aid advances in antitumour therapy 1,2 .
A rational design for facilitating innovative cell death modes can substantially aid advances in antitumour therapy 1,2 . Here we design and implement a unique mode of immunogenic membranolytic cell death (mLCD) in tumour cells, characterized by time-lagged rupture from the…
Sign in to learn & save →
The frontier is open to all. Sign in to learn this from first principles and save it to your knowledge base.